Increase/Decrease in Cash: The total change in cash for the company over the given period.
Biorestorative Therapies, Inc. (BRTX) had Increase/Decrease in Cash of $-0.83M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.15M |
|
$-14.42M |
|
-- |
|
$0.15M |
|
$15.37M |
|
$-15.22M |
|
$0.81M |
|
$-14.42M |
|
$-14.42M |
|
$-14.42M |
|
$-14.42M |
|
$-14.42M |
|
$-14.42M |
|
$-15.22M |
|
$-15.05M |
|
4.22M |
|
4.22M |
|
$-3.42 |
|
$-3.42 |
|
| Balance Sheet Financials | |
$11.39M |
|
$0.36M |
|
$1.22M |
|
$12.61M |
|
$1.06M |
|
-- |
|
-- |
|
$1.06M |
|
$11.53M |
|
$10.83M |
|
$11.55M |
|
4.71M |
|
| Cash Flow Statement Financials | |
$-6.43M |
|
$3.25M |
|
$2.35M |
|
$1.71M |
|
$0.89M |
|
|
Increase/Decrease in Cash |
$-0.83M |
$7.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.71 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
100.00% |
|
-10439.49% |
|
-10439.49% |
|
-10325.82% |
|
-9887.16% |
|
-9887.16% |
|
$-6.60M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
7.55 |
|
48.32 |
|
-124.98% |
|
-133.05% |
|
-114.30% |
|
-124.83% |
|
$2.45 |
|
$-1.56 |
|
$-1.52 |
|